glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Oncology Letters
Oncology Letters In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? Antibody drug conjugates: A new twist to overcome EGFR TKIs resistance in non small cell lung cancer ScienceDirect
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



